[Pharmacotherapy of rheumatic diseases].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000553:Ambulatory Care; D000962:Antimalarials / Q000627:therapeutic use; D006046:Gold / Q000627:therapeutic use; D006073:Gout / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007213:Indomethacin / Q000627:therapeutic use; D007270:Injections, Intra-Articular; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D010648:Phenylacetates / Q000627:therapeutic use; D010653:Phenylbutazone / Q000627:therapeutic use; D011720:Pyrazoles / Q000627:therapeutic use; D012216:Rheumatic Diseases / Q000188:drug therapy*; D012459:Salicylates / Q000627:therapeutic use; D014020:Tissue Extracts / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use; D062367:ortho-Aminobenzoates / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000962:Antimalarials; D007166:Immunosuppressive Agents; D009125:Muscle Relaxants, Central; D010648:Phenylacetates; D011720:Pyrazoles; D012459:Salicylates; D014020:Tissue Extracts; D014149:Tranquilizing Agents; D062367:ortho-Aminobenzoates; D006046:Gold; D010653:Phenylbutazone; D007213:Indomethacin
Die Pharmakotherapie der rheumatischen Krankheiten